# Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

> **NCT01683721** · — · UNKNOWN · sponsor: **ApniCure, Inc.** · enrollment: 1000 (estimated)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01683721
- **Lead sponsor:** ApniCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683721, "Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01683721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*